Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results
Go back to Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results| (NASDAQ: CRVS) | Delayed: 12.56 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.56 | 52 Week High | $17.77 | |||
| Open | $12.56 | 52 Week Low | $9.63 | |||
| Day High | $12.56 | P/E | N/A | |||
| Day Low | $12.56 | EPS | $0.00 | |||
| Volume | 6,674 | |||||

